XML 16 R5.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Millions
 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Cash flows from operating activities:    
Net income $ 265 $ 275
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 427 369
Deferred income taxes 39 18
Allowance for equity funds used during construction (15) (17)
Decoupling mechanism deferrals, net of amortization (11) 27
Gain (Loss) on Disposition of Other Assets 153 31
Other non-cash income and expenses, net 69 63
Changes in working capital:    
Decrease in accounts receivable, net (9) (64)
(Increase) in inventories (10) (2)
(Increase)/decrease in margin deposits 66 1
(Decrease) in accounts payable and accrued liabilities 43 67
Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 0 2
Other working capital items, net 37 28
Other, net (57) (44)
Net cash provided by operating activities 970 608
Cash flows from investing activities:    
Capital expenditures (899) (876)
Sales of Nuclear decommissioning trust securities 4 0
Purchases of Nuclear decommissioning trust securities (9) (4)
Other, net (12) (20)
Net cash used in investing activities (916) (900)
Cash Provided by (Used in) Financing Activity, Including Discontinued Operation [Abstract]    
Proceeds from Issuance or Sale of Equity 49 178
Payments on long-term debt (102) 0
Proceeds from Issuance of long-term debt 310 450
Issuance of commercial paper, net 0 (146)
Dividends paid (167) (148)
Other (19) (12)
Net cash provided by (used in) financing activities 71 322
Increase (Decrease) in cash and cash equivalents 125 30
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 137 35
Supplemental cash flow information is as follows:    
Cash paid for interest, net of amounts capitalized 146 121
Cash paid for income taxes, net (137) (14)
Increase (Decrease) in Other Regulatory Assets (6) (130)
Increase (Decrease) in Regulatory Liabilities $ (21) $ (16)